Latest News and Press Releases
Want to stay updated on the latest news?
-
INFORMATION PRESSERubrique : C.A. annuel 2020 Nanterre, le 10 février 2021 (après Bourse) Croissance organique de 2,6% en 2020 (non audités, en...
-
MONTRÉAL, 04 févr. 2021 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (« Osisko » ou la « Société ») (TSX et NYSE : OR) annonce qu’elle publiera ses résultats financiers pour le...
-
MONTREAL, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (“Osisko” or the “Corporation”) (OR: TSX & NYSE) announces that its fourth quarter and full year 2020 results will be...
-
Marel kynnir afkomu fjórða ársfjórðungs og ársuppgjör 2020 (allar upphæðir eru í evrum) Helstu atriði: Árið 2020 – Góð rekstrarniðurstaða og stefnumarkandi skref til vaxtar Pantanir námu...
-
EXECUTIVE SUMMARY 2020: Resilient profitability and strategic moves Orders received were EUR 1,234.1m (2019: 1,222.1m).The order book was EUR 415.7m (3Q20: 434.3m, 4Q19: 414.4m). Revenues were...
-
MARE NOSTRUM Accélération de la reprise au S2Chiffre d’affaires 2020 de 123,2 M€ Grenoble, le 27 janvier 2021 – 18h30 - Mare Nostrum, expert innovant des Ressources Humaines pour les PME/ETI,...
-
DUNMORE, Pa., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary The Fidelity Deposit and Discount Bank, announced its most recent dividend...
-
PRESS RELEASE27 January 2021 HINKLEY POINT C PROJECT UPDATE (1) Despite being affected by the Covid-19 health crisis, Hinkley Point C has made significant progress in 2020 on site, in the...
-
INFORMATION REGLEMENTÉE Le développement des programmes cliniques et plus particulièrement de l’essai de Phase III évaluant JTA-004 et de l’essai de Phase IIb évaluant ALLOB, se poursuit...
-
REGULATED INFORMATION Clinical programs running on schedule, including Phase III trial of JTA-004 and Phase IIb trial of ALLOB Extensive achievements in collaborations and partnerships to...